Double-Stranded RNA of Intestinal Commensal but Not Pathogenic Bacteria Triggers Production of Protective Interferon-β  by Kawashima, Tadaomi et al.
Immunity
ArticleDouble-Stranded RNA of Intestinal Commensal
but Not Pathogenic Bacteria Triggers
Production of Protective Interferon-b
Tadaomi Kawashima,1,2 Akemi Kosaka,1 Huimin Yan,1,3 Zijin Guo,4 Ryosuke Uchiyama,7 Ryutaro Fukui,8
Daisuke Kaneko,2 Yutaro Kumagai,10 Dong-Ju You,11 Joaquim Carreras,1 Satoshi Uematsu,9 Myoung Ho Jang,11,14
Osamu Takeuchi,10,15 Tsuneyasu Kaisho,5,12 Shizuo Akira,10 Kensuke Miyake,8 Hiroko Tsutsui,7 Takashi Saito,6,13
Ikuko Nishimura,2 and Noriko M. Tsuji1,4,*
1Biomedical Research Institute, National Institute for Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki 305-8566, Japan
2Research and Development Division, Kikkoman Corporation, Noda, Chiba 278-0037, Japan
3The Fifth Hospital of Shijiazhuang, Shijiazhuang, Hebei 050021, China
4Laboratory for Mucosal Immune Tolerance
5Laboratory for Host Defense
6Laboratory for Cell Signaling
RIKEN Research Center for Allergy and Immunology, Yokohama, Kanagawa 230-0045, Japan
7Department of Microbiology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan
8Division of Infectious Genetics
9Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccine
The Institute of Medical Science, The University of Tokyo, Shirokanedai, Tokyo 108-8639, Japan
10Laboratory of Host Defense
11Laboratory of Gastrointestinal Immunology
12Laboratory for Immune Regulation
13Laboratory for Cell Signaling
WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan
14Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang 790-784, Korea
15Laboratory of Infection and Prevention, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
*Correspondence: nm-tsuji@aist.go.jp
http://dx.doi.org/10.1016/j.immuni.2013.02.024SUMMARY
The small intestine harbors a substantial number of
commensal bacteria and is sporadically invaded by
pathogens, but the response to these microorgan-
isms is fundamentally different. We identified a
discriminatory sensor by using Toll-like receptor 3
(TLR3). Double-stranded RNA (dsRNA) of one major
commensal species, lactic acid bacteria (LAB),
triggered interferon-b (IFN-b) production, which pro-
tected mice from experimental colitis. The LAB-
induced IFN-b response was diminished by dsRNA
digestion and treatment with endosomal inhibitors.
Pathogenic bacteria contained less dsRNA and
induced much less IFN-b than LAB, and dsRNA
was not involved in pathogen-induced IFN-b induc-
tion. These results identify TLR3 as a sensor to small
intestinal commensal bacteria and suggest that
dsRNA in commensal bacteria contributes to anti-
inflammatory and protective immune responses.
INTRODUCTION
The innate immune system is capable of recognizing a wide va-
riety of microbial signals and of rapidly inducing a range of anti-
microbial and inflammatory responses. Among them, Toll-likereceptors (TLRs) play a critical role in innate immunity by recog-
nizing structurally conserved bacterial and viral components
(Akira et al., 2006). Whereas TLR2 and TLR4 recognize bacterial
cell wall components at the cell surface, TLR3, TLR7, and TLR9
recognize bacterial or viral nucleic acids in endosomes after
phagocytosis of bacteria or virus (Akira et al., 2006). Dendritic
cells (DCs) andmacrophages express TLRs and their recognition
of microbial components contributes to both rapid antipathogen
responses andmaintenance of homeostatic protective immunity
in healthy individuals (Medzhitov and Janeway, 1998; Beutler
et al., 2007).
Gut-associated lymphoid tissues (GALTs) are a major site of
host encounter with exogenous antigens and pathogens. Based
on a number of observations, including the poor immune
response of germ-free mice unless they are colonized with one
or more numbers of strains of commensal bacteria (Wu et al.,
2010; Schwarzer et al., 2011), it is now well recognized that the
interaction of GALT with microbiota regulates both the quality
and quantity of systemic immune responses. Moreover, oral
administration of selected strains of commensal bacteria was
shown to be effective to intervene in immune responses even in
conventionally reared mice (Atarashi et al., 2011; Jeon et al.,
2012).
The fermentative lactic acid bacteria (LAB) are aerobic and
abundant in the environment and food and they consequently
compose a major part of our small intestinal commensal flora
(Suzuki et al., 2004; Hao and Lee, 2004), and therefore they affect
maturation of host immune cells and maintenance of intestinalImmunity 38, 1187–1197, June 27, 2013 ª2013 Elsevier Inc. 1187
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IFN-b Response to Commensal Bacterial RNA via TLR3immune homeostasis under normal steady-state conditions
(Shida and Nanno, 2008). Oral administration of some strains
of LAB has been shown to stimulate the innate immunity at
mucosal sites and to enhance systemic immune responses
against pathogenic bacteria or viruses (Corr et al., 2007; Kawa-
shima et al., 2011; Kosaka et al., 2012). However, the mecha-
nisms by which such commensal bacteria are beneficial for
protective immunity and anti-inflammatory conditions and the
manner in which the immune system distinguishes these organ-
isms from potential pathogens that cause opportunistic and/or
immediate infection remain elusive.
We investigated the role of TLRs in the recognition of LAB by
the host immune system. TLRs are expected to play major roles
not only in the recognition of pathogenic microorganisms but
also in the interactions between indigenous bacteria and host im-
mune cells (Rakoff-Nahoum and Medzhitov, 2008). Although
pathogenic strains such asSalmonella Typhimurium and Escher-
ichia coli are known to stimulate TLR4 (Weiss et al., 2004), little is
knownmechanistically about how LAB or other commensal bac-
teria are recognized by the host immune system and eventually
fortify it. In the case of Bacteroides fragilis, a major flora in large
intestine, bacterial polysaccharide A signals through TLR2
directly on Foxp3+ regulatory T cells to promote immunologic
tolerance (Round et al., 2011). There are a few examples showing
a role of TLR2 in the recognition of peptidoglycans and lipotei-
choic acid of LAB (Grangette et al., 2005; Asong et al., 2009),
but the function of other TLRs remains largely unknown.
We elucidated the role of TLRs in the recognition of LAB and
provide evidence that commensal but not pathogenic bacteria
induce a robust interferon-b (IFN-b) response by recognition
through endosomal TLRs. Unlike IFN-a, IFN-b is not related to
systemic disorder such as autoimmune diseases, but rather is
dedicated to stabilize protective immunity against infection and
inflammation; therefore, the response to commensal bacteria is
expected to protect the host through IFN-b production. Further-
more, we have identified bacterial dsRNA as effective TLR3 li-
gands that serve to discriminate small intestinal commensals
from potential pathogens. These endosomal responses to
commensal bacteria should be beneficial as natural boosters
of gut protective immunity.
RESULTS
LAB Induce IFN-b from DCs In Vitro
The fermentative LAB are a major component of the small intes-
tinal microbiota and very often are contained in regular diet. We
started to analyze the immunological property of this group of
commensal bacteria in comparison with several pathogenic spe-
cies and found that IFN-b secretion from bone-marrow-derived
DCs (BMDCs) in response to LAB was generally much stronger
than that to pathogenic bacteria regardless of strain difference
(Figure 1A). Because IFN-b is an important mediator for antiviral
protective immunity and anti-inflammation, we assessed the
beneficial effect of IFN-b induced in BMDCs by coculturing
with a heat-killed LAB, Tetragenococcus halophilus strain
KK221. We confirmed that a large amount of IFN-b, but not
IFN-a, was secreted in response to this bacterium (Figure S1A
available online). These results suggest a possible beneficial ac-
tivity of LAB in innate protective immunity against viral infection.1188 Immunity 38, 1187–1197, June 27, 2013 ª2013 Elsevier Inc.To assess whether KK221 has a protective effect, BMDCs cocul-
tured with or without heat-killed bacteria were infected with
vesicular stomatitis virus (VSV), which is known to be sensitive
to type I IFNs (Obuchi et al., 2003). As expected, KK221 sup-
pressed VSV replication in the cells. This suppression was
mediated through secreted IFN-b as shown by the fact that the
addition of neutralizing IFN-b monoclonal antibodies (mAbs)
restored viral replication (Figure S1B).
LAB Induce Anti-inflammatory Effects through IFN-b
In Vivo
IFN-b is also a key anti-inflammatory cytokine in the settings of
experimental colitis (Katakura et al., 2005). With the dextran
sodium sulfate (DSS)-induced colitis model, we found that oral
administration of KK221 alleviated colonic inflammation. The
ameliorating effects were evident in a histological analysis of
the colon, by a reduced infiltration of inflammatory cells such
as neutrophils, eosinophils, and macrophages in lamina propria.
The inflammatory infiltration in the KK221-fed group was as se-
vere as that of saline-fed group after treatment with the neutral-
izing Ab against IFN-b (Figures 1B, 1C, S1C, and S1D). Oral
administration of LAB prevented the inflammatory signs
indicated by the colon length and myeloperoxidase (MPO) activ-
ity, a marker for neutrophil infiltration into tissue (Figures 1D
and 1E).
Expression of genes encoding inflammatory mediators such
as tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), Cxcl1,
and IL-17 in the inflamed colon (Alex et al., 2009) was also sup-
pressed by oral administration of KK221 (Figure 1F). As ex-
pected, these protective effects of oral LAB administration
were significantly reversed by injection of IFN-b mAb (Figures
1B–1F). Of importance, gene expression of IFN-b in CD11c+ lam-
ina propria cells was equally enhanced in mice with or without
the neutralizing Ab (data not shown). These results suggest
that the anti-inflammatory and protective effects observed in
the DSS-induced colitis model are mediated by IFN-b produc-
tion in the intestine upon recognition of LAB.
TLR3 and TLR9 Are Involved in IFN-b Secretion by
BMDCs in Response to LAB but Not Pathogenic Bacteria
To identify the components of LAB responsible for the protective
effect and the nature of their recognition by host cells, BMDCs
from mice deficient in various TLRs were analyzed. IFN-b secre-
tion by BMDCs upon coculture with KK221 was significantly
reduced in the absence of TLR3 and TLR9, whereas deficiency
of TLR2, TLR4, and TLR7 had no effect on IFN-b production (Fig-
ure 2A). Neither IL-6 nor TNF-a production was impaired by each
TLR deficiency (Figures S2A and S2B), indicating that the endo-
somal TLRs (TLR3 and TLR9) are specifically involved in IFN-b
secretion upon recognition of LAB by BMDCs. Moreover, the
mRNA expression of both TLRs was enhanced after exposure
to KK221 (Figure S2C).
Having clarified the nature of the response to LAB, we next
analyzed responses to a panel of LAB and pathogenic bacteria
strains by using Tlr3/ or Tlr9/ mice. First, we analyzed IFN-
b production by TLR3-deficient BMDCs stimulated with various
strains and species of heat-killed LAB aswell as pathogenic bac-
teria (Table S1). We found that the IFN-b response was induced
in a TLR3-dependent manner by a large proportion (five out of
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Figure 1. LAB Stimulates IFN-b Secretion
by BMDCs, Resulting in Anti-inflammatory
Immunity
(A) BMDCs from C57BL/6 mice were stimulated
with heat-killed bacteria (Table S1) for 6 hr. IFN-b
concentration was measured by ELISA. Data are
representative of three independent experiments.
(B–D) KK221-fed mice were treated with i.v. in-
jection of control Ab (Cont Ab) or IFN-bmAb (aIFN-
b) in DSS-induced colitis.
(B) Colon tissue sections were stained with H&E
(2003).
(C) Lamina propria lesion percentage in colon was
quantified.
(D) Colon length was measured.
(E and F) Mice were treated with i.v. injection
of Cont Ab or aIFN-b in DSS-induced colitis.
Colonic myeloperoxidase (MPO) activity (E) and
colonic mRNA expression (F) were measured.
Data are represented as mean ± SD relative to
saline-fed, Cont Ab-injected, and DSS-untreated
group (F).
Bars represent mean (A, C–E). *p < 0.05, **p < 0.01
(Student’s t test). See also Figure S1 and Table S1.
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IFN-b Response to Commensal Bacterial RNA via TLR3eight) of LAB (Figure 2B). In contrast, the lower responses to all
pathogenic bacteria tested, including Listeria monocytogenes
and Staphylococcus aureus, were intact in the absence of
TLR3 (Figure 2B).
Next, we determined the importance of the TLR9 pathway in
the recognition of various bacteria by using TLR9-deficient
BMDCs. The IFN-b responses to all LAB strains were signifi-
cantly impaired by TLR9 deficiency (Figure 2C). In contrast, the
response to all pathogenic bacteria strains tested was unaltered
by TLR9 deficiency (Figure 2C).
Thus, the response of BMDCs to LAB differs from that to path-
ogenic bacteria in two important aspects: they produce higher
amounts of IFN-b production and the response is dependent
on TLR3 and TLR9 (Figures 2B and 2C).
Endosomal Processing Is Required for IFN-b Secretion
in Response to LAB but Not Pathogenic Bacteria
Differential usage of endosomal TLRs to discriminate between
LAB and pathogenic bacteria was further confirmed by phar-Immunity 38, 1187–119macological inhibition of endosomal
function. Bacteria are digested in endo-
somes after phagocytosis, and their
components are recognized by endoso-
mal TLRs (Akira et al., 2006). NH4Cl
treatment neutralizes the acidic endo-
cytic compartments and/or delays en-
dosomal maturation without inducing
nonspecific inhibitory effects (Hotta
et al., 2006), thereby impairing LAB-
induced IFN-b production from BMDCs
(Figure 3A). Further, consistent with the
results in Figure 2A, this endosomal
pathway was specific to IFN-b produc-
tion as indicated by the fact that the
response of IL-6 and TNF-a was intactby the same treatment (Figure S3A). In contrast, IFN-b produc-
tion in response to pathogenic bacteria was much lower
and unaffected by NH4Cl (Figure 3A). Indeed, in contrast to
KK221, heat-killed Salmonella Typhimurium induced IFN-b
production by BMDCs only via TLR4 (Figure S3B). A major
dependency of this pathogenic strain to TLR4 was also
apparent in the production of other inflammatory cytokines
(Figure S3B). The distinct recognition manners reflect the fact
that IFN-b response to poly(I:C) and CpG DNA was impaired
by NH4Cl
 treatment, whereas the response to LPS was intact
(Figure 3B). To confirm the contribution of TLR3 and TLR9,
BMDCs from 3d mutant mice bearing a deficiency of
Unc93b1, which encodes an endoplasmic reticulum-resident
protein required for the trafficking of TLR3, TLR7, and TLR9
(Tabeta et al., 2006), were utilized. The 3d mutation completely
abolished IFN-b production by BMDCs in response to LAB
(Figure 3C). Thus, endosomal processing as well as endosomal
TLRs are requisite for the recognition of LAB and IFN-b
secretion.7, June 27, 2013 ª2013 Elsevier Inc. 1189
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Figure 2. TLR3 and TLR9 Are Involved in IFN-b Secretion by BMDCs
in Response to LAB but Not Pathogenic Bacteria In Vitro
(A) WT and TLR-deficient BMDCs were stimulated with heat-killed KK221 for
6 hr.
(B and C) WT and Tlr3/ (B) or Tlr9/ (C) BMDCs were cultured with heat-
killed bacteria (Table S1) for 6 hr.
IFN-b concentration wasmeasured by ELISA. Data are represented asmean ±
SD and representative of three independent experiments. *p < 0.05, **p < 0.01
(Student’s t test). Abbreviations are as follows: Tc, Tetragenococcus; Pc,
Pediococcus; Lb, Lactobacillus; LM, L. monocytogenes; ST, Salmonella Ty-
phimurium; CP,C. perfringens; HP,H. pylori; SA, S. aureus. See also Figure S2
and Table S1.
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IFN-b Response to Commensal Bacterial RNA via TLR3dsRNA in LAB Induces IFN-b Secretion by BMDCs
Despite both TLR3 and TLR9 being well-established receptors
for nucleic acids, recognition of bacteria via TLR3 has rarely
been described. The canonical TLR3 ligand is viral dsRNA, and
therefore the requirement of TLR3 for LAB recognition and in-
duction of IFN-b response suggests that bacterial dsRNA may
be physiological ligands in this innate immune response. We
tested this possibility by treating heat-killed KK221 with RNase
A under conditions in which the enzyme exhibits differential sub-
strate specificities. RNase A digests only ssRNA in the presence
of 0.3 M NaCl and digests both ssRNA and dsRNA in the
absence of NaCl (Ausubel et al., 1994). We also used S1
nuclease, an endonuclease that catalyzes specific degradation
of ssDNA and ssRNA. RNase A treatment of KK221 in the1190 Immunity 38, 1187–1197, June 27, 2013 ª2013 Elsevier Inc.absence of NaCl (Figure S4A) but not digestion of ssRNA
(0.3 M NaCl condition) resulted in a significant reduction of
IFN-b production (Figures 4A and 4B). This finding is consistent
with the results that TLR7-deficient BMDCs are impaired in
ssRNA recognition yet still mount a robust IFN-b response to
KK221 (Figure 2A). As expected, dsRNA depletion of KK221 low-
ered the amount of induced IFN-b in WT BMDCs to the amount
comparable to TLR3-deficient cells (Figure 4C). IFN-b response
to RNase A (0 M NaCl)-treated KK221 was abolished in TLR9-
deficient cells (Figure 4C), indicating that the combination of
TLR3 and TLR9 totally accounts for the IFN-b production from
BMDCs. In contrast, IFN-b production from BMDCs triggered
by Salmonella Typhimurium or Helicobacter pylori was not
altered after RNase A-treatment of those pathogenic bacteria
(Figure 4D).
To further clarify the characteristics of bacterial RNA, dsRNA
extracted from various bacteria was quantified by ELISA via
mAb specific for dsRNA (Scho¨nborn et al., 1991). In line with
our findings, LAB strains contained higher amounts of dsRNA
than the pathogenic bacteria examined (Figures 4E and S4B).
Treatment of the samples with RNase III, which digests dsRNA,
completely abolished the ELISA signals (Figure S4B). We have
used heat-killed bacteria on the assumption that a considerable
amount of LAB in the gut is not alive under physiological con-
dition, and such heat-killed LAB as probiotics is applicable to
intervene in immune responses. We found that heat-killing treat-
ment preserves the total amount of dsRNA in bacteria such as
Salmonella Typhimurium and KK221 whereas major RNA com-
ponents were significantly decreased, consistent with the ob-
servation of Sander et al. (2011) (Figures S4C and S4D). Thus
stimulatory function of bacterial dsRNA should remain intact
even after heat-killing treatment. In fact, the amount of dsRNA
in heat-killed KK221, which is increased by high-salt stress dur-
ing bacteria culture, was correlated with the enhanced IFN-b
secretion from BMDCs (Figures S4E and S4F).
We observed that heat-killed KK221 induces a considerable
amount of cytokines compared to live bacteria. Reduction of
the IFN-b response is comparable to that of IL-6 and TNF-a, indi-
cating that heat killing caused denaturation of the ligands for re-
ceptors other than TLR3 (Figure S4G).
Contents in theSmall Intestine andCommensal Bacteria
Stimulate TLR3-Mediated IFN-b Secretion by BMDCs
To examine the role of TLR3 in response to fresh gut microflora,
intestinal contents including commensal bacteria were har-
vested from specific-pathogen-free mice and applied to BMDC
culture. The TLR3 dependency was observed for the ileum con-
tents, as well as highest production of IFN-b, whereas the
amount of IL-6 and TNF-a was not affected by TLR3 deficiency
(Figure 5A). It is important that TLR3 seems to have a physiolog-
ical role in small intestine where LAB is amajor component of gut
flora. These results are consistent with the observation that ileal
contents have the highest amount of dsRNA among jejunum,
ileum, cecum, and colon (Figure S5A). The colon, which has
the second highest amount of dsRNA in the intestine, seems
related to neither higher IFN-b production nor TLR3 dependency,
suggesting the presence of Salmonella Typhimurium-type bac-
teria whose IFN-b production is more dependent on TLR4 (Fig-
ures S3B and S5B). This may also explain the different state
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Figure 3. Requirement of Endocytic Pro-
cessing for IFN-b Response to LAB by
BMDCs
(A and B) BMDCs fromBALB/cmice were cultured
with heat-killed bacteria (Table S1) (A) and TLR li-
gands (B) in the presence of NH4Cl for 6 hr.
(C) WT and Unc93b13d (3d) BMDCs were stimu-
lated with heat-killed LAB for 6 hr.
IFN-b concentration was measured by ELISA.
Data are represented as mean ± SD and repre-
sentative of at least two independent experiments.
*p < 0.05, **p < 0.01 (Student’s t test). Abbrevia-
tions are as in Figure 2. See also Figure S3 and
Table S1.
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IFN-b Response to Commensal Bacterial RNA via TLR3for small versus large intestine: in the contrast between LAB and
opportunistic pathogenic bacteria as components of their
respective commensal flora, and further, its relevance to an
anti-inflammatory feature of small intestine.
In the present study, we isolated small intestinal commensal
LAB and cocultured with BMDCs (as described in Table S2).
Out of 11 strains, 8 induced significant amount of IFN-b, with
prominent dependency on TLR3 for most of highly efficient
inducers (5/8: Lactobacillus jonsonii No. 1-17, No. 2-13; Lacto-
coccus lactis No. 3-2, No. 4-4, Lactobacillus intestinalis No.
3-8) (Figure 5B). Interestingly, the frequency was similar to that
obtained with heat-killed LAB from established culture collec-
tions (Figure 2B). The importance of endosomal recognition for
these small intestinal LAB was confirmed by using Unc93b13d
BMDCs (Figure 5C).
These results suggest that an appreciable amount of
commensal bacteria in the ileal microflora enhances the level
of IFN-b expression through TLR3 under physiological steady-
state conditions.
TLR3 Is Involved in Anti-inflammatory Effects of Oral
Administration of LAB
When IFN-b mRNA expression in intestinal epithelial cells (IECs)
and lamina propria cells were compared, the amount in lamina
propria was much higher than that in IECs and was significantly
decreased by TLR3 deficiency (Figure S5C). We confirmed that
TLRs other than TLR3 were equally expressed in lamina propria
cells of WT and Tlr3/mice (Figure S5D). This finding is consis-
tent with our observation with BMDCs showing that induction of
IFN-b in the coculture with contents of small intestine was
reduced by TLR3 deficiency (Figures 5A and S5C). Moreover,
although IFN-b expression in CD11c+ cells was enhanced in
WT mice by oral administration of KK221 (oral KK221), it wasImmunity 38, 1187–119not the case for Tlr3/mice in both intes-
tinal and systemic organs (Figures 6A–
6C). These results indicate that TLR3 is
important for IFN-b production through
activation of CD11c+ cells in vivo.
Accordingly, luminal environment in
Tlr3/ mice may be less anti-inflamma-
tory with reduced IFN-b response, and
indeed Tlr3/ mice were more suscepti-
ble to DSS-induced colitis (Figure 6D).
Moreover, infiltration of inflammatory im-mune cells was prominent in Tlr3/ mice even after oral
KK221, which is otherwise protective in WT mice. Although
KK221 treatment reversed the intensity of the lesions in WT
mice, it failed to attenuate the lesions in the Tlr3/ group (Fig-
ures 6D and 6E). All other inflammatory signs indicated by colon
length, MPO activity, body weight, and expression of soluble
mediators support these observations (Figures 6F–6I).
dsRNA in LAB Plays a Central Role to Alleviate
Inflammation in DSS-Induced Colitis
Nucleic acids are strong stimulator of innate immune system
and we observed LAB trigger the production of IFN-b via TLR3
and TLR9 in vitro (Figure 4C), suggesting that both dsRNA and
DNA are possibly protective components of LAB. However,
TLR3 deficiency canceled out the anti-inflammatory effect of
oral KK221 in vivo (Figures 6D–6I). Therefore, it is important
to assess the contribution of dsRNA to the protective effect
under physiological conditions. dsRNA-free LAB was prepared
by treating KK221 with RNase A (0 M NaCl) and orally adminis-
tered to mice. The results from experimental colitis clearly
showed that dsRNA in KK221 is required to exert the anti-inflam-
matory effect (Figures 7A–7D and S6A), confirming the central
role for dsRNA in vivo. Oral KK221 partially protected Tlr9/
mice in terms of colon length and MPO activity of which effect
was again erased in the case of RNase A (0 M NaCl)-treated
KK221 (Figures 7A and 7B).
We cannot exclude the role of TLR9 in the full protective func-
tion downstream of TLR3 (dsRNA) because the suppression
level was less significant in Tlr9/ mice and such effect of
KK221 was completely abolished in Unc93b13d mice (Figures
7A–7D) as it was in Tlr3/ mice (Figures 6D–6I). In connection
with it, we observed in vitro that expression of IFN regulatory fac-
tor 7 (IRF7), an essential molecule for IFN-b induction (Honda7, June 27, 2013 ª2013 Elsevier Inc. 1191
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Figure 4. dsRNA of LAB Induces IFN-b
Secretion by BMDCs in Response to LAB
(A) BMDCs from BALB/c mice were cultured with
untreated or RNase A (0 M NaCl)-treated heat-
killed KK221 for the indicated period.
(B) BMDCs from BALB/c mice were cultured with
heat-killed KK221 treated with RNase A (0 or 0.3 M
NaCl) or S1 nuclease for 6 hr.
(C) WT, Tlr3/, Tlr9/, and Unc93b13d (3d)
BMDCs were stimulated with untreated or RNase
A (0 M NaCl)-treated heat-killed KK221 for 6 hr.
(D) BMDCs from BALB/c mice were cultured with
untreated or RNase A-treated (0 or 0.3 M NaCl)
heat-killed Salmonella Typhimurium (ST) and
H. pylori (HP) for 6 hr.
IFN-b concentration was measured by ELISA.
Data are represented as mean ± SD and are
representative of three independent experiments.
(E) dsRNA in heat-killed bacteria was detected by
a sandwich ELISA. dsRNA concentration was
quantified by ELISA. Tested LAB are described in
Table S1A and tested pathogenic bacteria are ST,
HP, and S. aureus (SA). Data are representative of
two independent experiments.
*p < 0.05, **p < 0.01 (Student’s t test). See also
Figure S4 and Table S1.
Immunity
IFN-b Response to Commensal Bacterial RNA via TLR3et al., 2005), was enhanced by LAB stimulation but reduced by
RNase A treatment (0 M NaCl) of LAB (Figure S6B).
It has been shown that DNA derived from luminal bacteria con-
tributes significantly to the perpetuation of chronic intestinal
inflammation via TLR9 and therefore the inflammation of Tlr9/
mice as suchwasmilder compared toWTmice (Obermeier et al.,
2005). Thus, under physiological settings, it seems that TLR9 is
involved in the induction of large intestinal inflammation whereas
TLR3 mainly contributes to the anti-inflammatory mechanism in
small intestine through recognition of dsRNA from LAB.
DISCUSSION
We show here that dsRNA from LAB triggers TLR3-mediated
IFN-b secretion by DCs in the gut. It was also found that TLR3
is important for recognizing ileal luminal contents and
commensal bacteria, thereby affecting IFN-b production in small
intestine under physiological conditions.
Unlike IFN-a, IFN-b is not related to autoimmune diseases,
but rather is involved in enhancing protective and Th1 cell
immunity. IFN-a, which is most probably produced by plasma-
cytoid DCs, has been shown to contribute to the pathogenesis
of inflammatory conditions such as autoimmune systemic lupus
erythematous, multiple sclerosis, and skin wounds (Bancher-
eau and Pascual, 2006; Lande et al., 2008; Gregorio et al.,
2010). In contrast, IFN-b is suggested to stabilize immune
homeostasis (Teige et al., 2003). It has been reported that
subcutaneous injection but not oral administration of the
TLR3 ligand, poly(I:C), which activates IFN-b production,
suppressed DSS-induced colitis (Vijay-Kumar et al., 2007).
Consistently, we showed here that DSS-induced colitis was
suppressed by oral administration of LAB through IFN-b induc-
tion. That oral LAB has the advantage over oral poly(I:C) is
probably reasoned by the nature of LAB to resist digestion in1192 Immunity 38, 1187–1197, June 27, 2013 ª2013 Elsevier Inc.the gut and by their spheroidal or rod shape to be easily phago-
cytosed by DCs.
Bacteria recognition through TLR3 pathway directly contrib-
utes to IFN-b production, thereby enhancing both protective
and anti-inflammatory response.We identified dsRNA, a compo-
nent of commensal bacteria, as natural ligands for TLR3 to
induce IFN-b. This TLR3-dependent pathway seems to involve
activation of TLR7 and TLR9 for sufficient IFN-b induction (Gaut-
ier et al., 2005). More specifically, stimulation of TLR7 and/or
TLR9 is required for phosphorylation of IRFs, which is essential
for the full induction of IFN-b (Honda et al., 2005). We demon-
strated that IRF7 expression required for TLR9 signaling was
enhanced by LAB stimulation and that RNase A-treated LAB
suppressed this enhancement. These observations suggest
that TLR3 contributes to enhancing TLR9-mediated IFN-b
production through augmenting IRF response, and in turn,
TLR9 ligands are important costimulators for the IFN-b produc-
tion initiated by dsRNA via TLR3, as well as being potent IFN-b
inducers themselves.
The cooperative and additive effects of dsRNA as TLR3 li-
gands and DNA as TLR9 ligands in vitro are also clarified with
Unc93b13d mice, which are defective in TLR3, TLR7, and TLR9
signaling. In this mutant mouse, IFN-b production by BMDCs
was abolished, indicating that endosomal TLRs are essential
for this activity. Because TLR7 is less involved in our experi-
mental system, it is clear that an additive and/or sequential
role of TLR3 and TLR9 pathways represent major effects of
this LAB-induced IFN-b production. Therefore, DNA should
partially activate BMDCs to produce IFN-b and explains the re-
sidual amount of IFN-b production after digestion of dsRNA
in vitro.
However, TLR9 deficiency caused less pathology in a DSS-
induced colitis model, suggesting that the role of TLR9 in the
intestine is as a danger-sensing machinery that potentially
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Figure 5. The Intestinal Contents of Mice
andCommensal LAB Isolated fromSmall In-
testine Stimulate TLR3-Mediated IFN-b
Secretion by BMDCs
(A) WT and Tlr3/ BMDCs were stimulated with
the intestinal contents for 6 hr.
(B) WT and Tlr3/ BMDCs were stimulated with
commensal LAB isolated from the small intestine
of mice (Table S2) for 6 hr.
(C) WT and Unc93b13d BMDCs were stimulated
with commensal LAB for 6 hr.
IFN-b, IL-6, and TNF-a concentrations were
measured by ELISA. Data are represented as
mean ± SD and are representative of two inde-
pendent experiments. *p < 0.05, **p < 0.01 (Stu-
dent’s t test). See also Figure S5 and Table S2.
Immunity
IFN-b Response to Commensal Bacterial RNA via TLR3promotes inflammation. In contrast, deletion of TLR3 aggravates
the disease. Thus, our findings indicate the discrete roles of
TLR3 and TLR9 in vivo, despite their additive and cooperative ef-
fects for IFN-b production from BMDCs in vitro.
In connection with the anti-inflammatory nature of TLR3
activation in vivo, TLR3 ligands seem less efficient to induce in-
flammatory cytokines such as IL-6 and TNF-a as compared with
IFN-b, ensuring the anti-inflammatory cytokine milieu in the site
where the TLR3 pathway is active. Our finding that ileum con-
tents stimulate the TLR3-mediated pathway most efficiently
may partially contribute to the anti-inflammatory feature of small
intestine.
Endosomes were identified as the intracellular sites of LAB
recognition. In addition to TLR3, two RNA helicases have been
shown to be cytosolic sensors of dsRNA: retinoic acid-inducible
gene I (RIG-I) and melanoma differentiation-associated gene 5
(MDA5) (Kato et al., 2006). Certain viruses or dsRNA activate a
TLR-independent pathway through RIG-I or MDA5, which are
recruited by IFN-b promoter stimulator 1 (IPS-1), an adaptor
molecule localized on the mitochondrial membrane, thereby
stimulating IRF3 and IRF7 (Kumar et al., 2006). However, we
found that IPS-1 deficiency had no effect on IFN-b induction
by heat-killed LAB (data not shown), thus suggesting that TLR3
and TLR9 in endosomes, but not the cytoplasmic innate recep-
tors, are critically involved in the recognition of commensal bac-
teria for IFN-b induction. Therefore, considering that the RIG-I
pathway is known to be a major route of viral RNA recognitionImmunity 38, 1187–119by conventional DCs, it is possible that
TLR3 is specifically involved in bacterial
dsRNA recognition toward induction of
protective immunity such as Th1 cell re-
sponses, and at the same time support
the maintenance of immune homeostasis
via anti-inflammatory cytokines. It has
been also shown that TLR3 facilitates
cross-priming by conventional DCs dur-
ing virus infection by phagocytosis of in-
fected cells (Schulz et al., 2005). The
TLR3 pathway may promote cellular pro-
tective immunity whereas RLRs are more
efficient in immediate recognition of virus
infection.The contents in the small intestine induced IFN-b secretion by
BMDCs, suggesting that CD11c+ DCs in lamina propria or
Peyer’s patches may also be activated to produce IFN-b by
commensal bacteria, especially by LAB. We confirmed this
speculation by isolating strains of LAB from small intestine and
observed that they induced BMDCs to secrete IFN-b through
TLR3. In the gut, it has been shown that bacteria translocate to
lamina propria via M cells (Jang et al., 2004) or that some
CD11c+ cells express tight junction proteins and penetrate gut
epithelial monolayers to sample bacteria directly (Rescigno
et al., 2001). Phagocytosis of bacteria by intestinal DCs and
digestion of cell body in endosome may then occur subse-
quently. This pathway should contribute to physiological homeo-
stasis of the mucosal immune system. In this regard, mice at
weaning, a time when they are experiencing profound changes
in the intestinal microenvironment and microbial flora, undergo
a surge of IFN-b production (S. Rakoff-Nahoum and R. Medzhi-
tov, personal communication).
In the present study, we also demonstrate a contrast between
LAB and pathogenic bacteria in their ability to induce IFN-b pro-
duction through TLR3. Our findings define a role for TLR3 in the
small intestine, not just as a sensor of RNA viruses (Kawai and
Akira, 2009) and necrotic self (Kariko´ et al., 2004) but also as a
sensor of commensal bacteria, where it responds by amplifying
IFN-b production. These findings indicate a unique characteristic
of small intestine: symbiotic bacteria stimulate CD11c+ cells by
dsRNA under normal steady-state conditions. There have been7, June 27, 2013 ª2013 Elsevier Inc. 1193
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Figure 6. Oral-LAB Alleviates DSS-Induced
Colitis through TLR3
(A and B) WT and Tlr3/ mice were treated with
heat-killed KK221. After 15 hr, IFN-b mRNA
expression in CD11c+ cells from Peyer’s patches
(A, PP) and mesenteric lymph nodes (B, MLN) was
measured.
(C) Heat-killed KK221 was orally administered to
WT and Tlr3/ mice for 14 days. IFN-b mRNA
expression in CD11c+ cells from spleens (SP) was
measured.
Data are represented as mean ± SD relative to
saline-treated controls of two independent exper-
iments.
(D–I) WT and Tlr3/ mice were treated with heat-
killed KK221 in DSS-induced colitis.
(D) Colon tissue sections were stained with H&E
(original magnification 2003). In Tlr3/ mice,
KK221 treatment failed to attenuate an infiltration
of neutrophils, eosinophils, and macrophages.
(E–I) Lamina propria lesion percentage in colon (E),
body weight (F), colon length (G), colonic MPO
activity (H), and colonic mRNA expression (I) were
measured. Values are relative to saline-fed group
(H, I). Data are represented as mean ± SD (F, I).
Bars represent mean (E, G, H).
*p < 0.05, **p < 0.01 (Student’s t test).
Immunity
IFN-b Response to Commensal Bacterial RNA via TLR3some reports that oral administration of LAB enhances protec-
tive immunity against viruses and pathogenic bacteria (Corr
et al., 2007; Kawashima et al., 2011). Importantly, the anti-inflam-
matory effect of oral LAB in the DSS-induced colitis model was
highly dependent on dsRNA in LAB. LAB can thereby benefit
the host immune system and may have coevolved to become
major commensal bacteria in the small intestine. We conclude
that commensal bacteria-induced IFN-b production by DCs is
a physiological response, which stabilize protective immunity.
It is also suggested that utilization of dietary supplements, which
take advantage of such physiological mechanisms, is a secure
way to improve immune responses and immune homeostasis.
The mechanism for the preferential stimulation of the TLR3
pathway by dsRNA from small intestinal commensal bacteria,
at least in part, may be attributed simply to be quantitative level:
LAB contain much higher levels of dsRNA than the other species
including pathogenic bacteria. Our observation that KK221
which had been manipulated to contain more dsRNA induced
more IFN-b production supports this idea. However, some of1194 Immunity 38, 1187–1197, June 27, 2013 ª2013 Elsevier Inc.the bacterial strains did not exhibit simple
quantitative correlation. In such strains,
stimulation by other TLR ligands in the
bacteria or digested bacterial compo-
nents in endosomes could also be
involved in IFN-b induction. For instance,
TLR4 is preferentially involved in IFN-b
production upon stimulation with Salmo-
nella, and it has been reported that the
resistance of bacterial cell wall compo-
nents to digestive enzymes in endosomes
is related to the induction of inflammatory
cytokines (Shida et al., 2006). However, itis stressed that in vivo, dsRNA stimulation via TLR3 played a
central role for the protective effect of oral LAB. Mechanisms
of predominant role for TLR3 in vivo need to be further clarified.
dsRNA is typically observed in viruses. In bacteria, multiple
small noncoding RNAs are known to be involved in posttran-
scriptional gene regulation, often in response to stress. In
E. coli, a small RNA (RyhB) is synthesized when iron is limited
and binds to target mRNA to form dsRNA (Masse´ and Gottes-
man, 2002). Therefore, not only LAB but also other species of
bacteria may increase the amount of dsRNA under various con-
ditions. Recently, clustered regularly interspaced short palin-
dromic repeats (CRISPR), whose size is as small as less than
50 bps, has been reported to provide themechanism for upregu-
lating acquired immunity against viruses and plasmids (Horvath
and Barrangou, 2010). In fact, multiple CRISPR families have
been identified within LAB species including Lactobacillus (Hor-
vath et al., 2009). Considering that TLR3 can bind to 40–50 bp
segments of dsRNA (Leonard et al., 2008; Liu et al., 2008), our
findings may suggest that LAB provides such a length of dsRNA,
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Figure 7. dsRNA in LAB Alleviates Inflam-
mation in DSS-Induced Colitis
Saline-treated, untreated, or RNase A (0 M NaCl)-
treated heat-killed KK221 was orally administered
to WT, Tlr9/, and Unc93b13d (3d) mice in DSS-
induced colitis. Colon length (A), colonic MPO
activity (B), and colonic mRNA expression (C) were
measured. Lamina propria lesion percentage in
colon (D) was quantified. Data are represented as
mean ± SD relative to saline-fed group in each
strain (C). Bars represent mean (A, B, D). *p < 0.05,
**p < 0.01 (Student’s t test).
See also Figure S6.
Immunity
IFN-b Response to Commensal Bacterial RNA via TLR3including CRISPR families, to DCs for IFN-b production. Further
analysis of dsRNA may clarify the quantitative difference of
dsRNA between LAB and pathogenic bacteria.
On the other hand, in the intestine, stimulation of TLRs other
than TLR3 by pathogenic bacteria may cause occasional inflam-
mation and discriminate them from less-inflammatory strains
worthy to become cohabitants. Considering that dsRNA-
TLR3-mediated activation of DCs contributes to gut ho-
meostasis, there may have been strong selection in the gut for
commensals with higher levels of dsRNA. LAB can grow and
thrive under low pH conditions (Williams, 2010). By producing
lactic acid, LAB protects the gut microflora community from
overgrowth of pathogenic bacteria by lowering the pH. Environ-
mental conditions, such as pH or nutrition, seem to affect the
dsRNA content of bacteria and may help distinguish between
commensal bacteria that stabilize immune homeostasis and
pathogenic bacteria that may as well be involved in opportu-
nistic infection and cause inflammatory conditions. Such envi-
ronmental factors that determine or modify the contents of
dsRNA or TLR ligands in bacteria should be clarified and are
now under investigation.Immunity 38, 1187–119EXPERIMENTAL PROCEDURES
Bacteria
Tetragenococcus halophilus KK221was cultured
in MRS broth (Difco) containing 10% (w/v) NaCl.
Other species of LAB were cultured in MRS broth.
Heat-killed pathogenic bacteria were prepared by
Hyogo College of Medicine. Strain numbers and
names of the tested bacteria are listed in Tables
S1 and S2. Nuclease treatment of bacteria and
isolation of intestinal LAB are described in the
Supplemental Experimental Procedures.
Mice
6- to 10-week-old female BALB/c or C57BL/6 mice
were purchased from SLC Japan or Japan Crea.
TLR-deficient C57BL/6 mice were provided by Hy-
ogo College of Medicine, RIKEN, The University of
Tokyo, or purchased from Oriental Bioservice.
Unc93b13d mutant C57BL/6 mice were kindly pro-
vided by B. Beutler (Southwestern University).
Mice were maintained according to the respective
institutional guidelines. Animal experiments were
approvedby theAnimalWelfareCommitteeofAIST.
Preparation of BMDCs
Bone marrow cells were collected from tibiae and
femurs. After red blood cell lysis and depletion ofCD4-, CD8-, and I-A/I-E-expressing cells, the cells were cultured in RPMI
1640 (Gibco) containing 10% fetal bovine serum and 10% granulocyte macro-
phage colony-stimulating factor (GM-CSF). On day 8, nonadherent and loosely
adherent cells were harvested (see also the Supplemental Experimental
Procedures).
Reagents
A mAb to mouse IFN-b was purchased from Yamasa Co. A rat IgG1 Ab
(eBioscience) was used as the isotype control Ab. Poly(I:C), LPS, and CpG
DNA (ODN 1826) were purchased from Invivogen.
Cell Culture
BMDCs were cultured in 96-well flat-bottomed culture plates at 23 105 cells/
well/200ml in the presenceor absenceof 13107bacteria. For inhibition of acid-
ification in endosomes, BMDCs were preincubated under 1 or 5 mM NH4Cl.
Thereafter 1 3 107 bacteria were added and cocultured for 6 hr. The contents
of jejunum, ileum, cecum, and colon were added to cell culture medium,
adjusted to 0.25 of absorbance (600 nm), and cocultured for 6 hr. Poly(I:C)
(50mg/ml), LPS (10mg/ml), andCpGDNA (10mg/ml)wereaddedasTLR ligands.
Measurement of Cytokines in Supernatants
The cytokine concentrations were determined with the Mouse OptEIA ELISA
set (BD Bioscience). The IFN-b concentration was determined with the Mouse
IFN-b ELISA kit (PBL Biomedical Laboratories).7, June 27, 2013 ª2013 Elsevier Inc. 1195
Immunity
IFN-b Response to Commensal Bacterial RNA via TLR3In Vivo Studies
To induce experimental colitis to WT, TLR-deficient, and Unc93b13d mutant
C57BL/6 mice (n = 4–6), distilled water containing 3% (w/v) DSS (MP Bio-
medicals) was provided ad libitum for 7 days. Saline or heat-killed KK221
(13 109/day) was orally administered for 14 days from 7 days before induction
of experimental colitis. Control Ab or IFN-b mAb (50 mg/mouse) was injected
intravenously every 2 days. After 7 days of DSS administration, colon tissue
was collected from each mouse.Histological Analysis
Colon tissue sections were stained with H&E. The numbers of fields with lam-
ina propria inflammation in colon were quantified and the percentage calcu-
lated with Olympus BX53 Biological Microscope (Olympus Corporation) at
2003 original magnification and digital imaging system (Ventana iScan Coreo
AW v.3.3.1 and Image Viewer v.3.1; Ventana Medical Systems). Histological
analysis is described in detail in the Supplemental Experimental Procedures.Determination of MPO Activity
Colon tissues were homogenized in 50 mM phosphate buffer (pH 6.0) contain-
ing 0.5% hexadecyltrimethyl-ammonium bromide, frozen and thawed three
times, and centrifuged. An aliquot of the supernatant was used for determina-
tion of enzyme activity as described (Vijay-Kumar et al., 2007).Quantitative RT-PCR
Total RNA was extracted from the cells or tissue samples with TRIzol reagent
(Invitrogen). cDNA obtained by reverse transcription via PrimeScript RT re-
agent (Takara) was amplified with specific primers (Table S3) and SYBR Pre-
mix Ex Taq (Takara). Each mRNA expression level was normalized with
b-actin.Analysis of dsRNA in Bacteria
Nucleic acid was extracted from heat-killed bacteria (see also Supplemental
Experimental Procedures). The concentration of bacterial dsRNA was deter-
mined by sandwich ELISA with the mAb K1 and the biotinylated mAb J2 (En-
glish and Scientific Consulting) for detection (Scho¨nborn et al., 1991) followed
by streptavidin peroxidase (Zymed). The concentration of dsRNA was calcu-
lated with poly(I:C) as a standard.Statistical Analysis
Error bars indicate standard deviation. Statistical significance was determined
by a two-tailed Student’s t test for unpaired data.SUPPLEMENTAL INFORMATION
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